Elicio Therapeutics, Inc. (ELTX) AI Dilution Summary

Estimated cash was $36,423,315 as of 2026-07-06, rolled forward from $23,480,000 at 2026-06-30 against estimated monthly burn of $3,301,667. The company funds itself through an active $100,000,000 ATM with B. Riley, JonesTrading and Ladenburg Thalmann, with 3,378,094 shares sold since the program began through 2026-06-30 and sales after 2026-06-30 not yet reported; separately, a registered direct offering on 2026-07-06 raised $13,600,000 net from 4,380,313 shares.